Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.02−0.02 (-0.98%)
Close on Nov 17, 2026Market cap $191.00MP/E 5.3Yield –
Compugen pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Compugen's pe ratio was 5.5× on Nov 11, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.5× | – |
See a number that looks wrong?